DT
RGNX icon

Diversified Trust’s Regenxbio RGNX Stock Holding History

Diversified Trust’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,499
Closed -$130K – 1182
2026
Q1 		$130K Buy
15,499
+2,121
+16% +$22.3K ﹤0.01% 1000
2025
Q4 		$193K Buy
13,378
+2,615
+24% +$32.6K ﹤0.01% 977
2025
Q3 		$104K Hold
10,763
– – ﹤0.01% 967
2025
Q2 		$88.4K Buy
10,763
+411
+4% +$3.44K ﹤0.01% 910
2025
Q1 		$74K Hold
10,352
– – ﹤0.01% 899
2024
Q4 		$80K Hold
10,352
– – ﹤0.01% 892
2024
Q3 		$109K Hold
10,352
– – ﹤0.01% 869
2024
Q2 		$121K Buy
+10,352
New +$161K ﹤0.01% 821

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Diversified Trust's RGNX Position: Q2 2026 in Review

Diversified Trust sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 15,499 shares — an estimated $130K sold.

Diversified Trust first reported a position in RGNX in Q2 2024 and held it in 8 quarters. The position peaked at $193K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Diversified Trust reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • Diversified Trust sold 15,499 Regenxbio shares in Q2 2026, an estimated $130K.
  • Diversified Trust first reported a position in Regenxbio in Q2 2024 and held it in 8 quarters.
  • Diversified Trust's Regenxbio position peaked at $193K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.